Previous close | 16.70 |
Open | 16.70 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 430.00 |
Expiry date | 2025-01-17 |
Day's range | 16.70 - 16.70 |
Contract range | N/A |
Volume | |
Open interest | N/A |
On June 3, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 3,250 shares of the company.
The stock market was mixed Monday, but once again closed strong. Nvidia jumped while Meta and Spotify are stocks near buy points.
On May 31, 2024, Ourania Tatsis, EVP, Chief Regulatory & Quality Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 4,600 shares of the company.